Sarasota, FL, Dec. 12, 2016 -- Zion Research has published a new report titled “Hemostasis Products Market (Topical Hemostasis, Infusible Hemostasis, and Advanced Hemostasis) for Trauma, Surgery, Hemophilia, Myocardial Infarction, Stroke, and Thrombosis Applications: Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 - 2021”. According to the report, the global hemostasis products market was valued at approximately USD 5.30 billion in 2015 and is expected to reach approximately USD 6.70 billion by 2021, growing at a CAGR of around 4.0% between 2016 and 2021.
Hemostasis is a process which helps to cease the bleeding and keep blood within a damaged blood vessel. Hemostasis products are medical products used to stop bleeding and hemorrhage caused by injuries and surgical procedures. These products vary based on their mechanism of action, ease of application, composition, immunogenicity, adherence to tissue, and cost.
Browse through 27 Market Tables and 18 Figures spread over 110 Pages and in-depth TOC on “Global Hemostasis Products Market: By Product, Application, Industry Size, Share, Trends, Segment, Analysis, and Forecast 2015-2021”.
Request free Sample copy of Hemostasis Products Market Report @ https://www.zionmarketresearch.com/sample/hemostasis-products-market
The hemostasis product market is anticipated to witness noticeable growth over the next six years on account of growing demand supported by rising surgery volumes. Moreover, rapid growth in geriatric population base and rising prevalence of chronic conditions are other impacts rendering drivers of hemostasis product market. According to the CDC statistics, more than 45% of the American population suffers from at least one chronic condition requiring important care. However, slow adoption of advanced hemostasis instruments in emerging economies and the high cost of devices may curb the market growth in the near future.
Nonetheless, emerging market in developing countries is expected to open up new growth avenues within the forecast period. Some of the key product in this market includes topical hemostasis, infusible hemostasis, and advanced hemostasis. The topical hemostats are further classified into collagen, oxidized regenerated cellulose, gelatin, and polysaccharide. Infusible hemostasis includes platelet concentrates from donor blood, FVIII derived from blood, fresh frozen plasma, and prothrombin complex. Topical hemostats were the leading segment and it accounted for significant share of total revenue generated in 2015. Topical hemostats are generally used in adjunction with conventional treatment to provide minimal tissue reactivity, quick and easy absorbability of the hemostatic agent, non-antigenicity, and cost-efficiency. Infusible hemostasis and advanced hemostasis are expected to witness exponential growth over the forecast period.
Browse the full "Hemostasis Products Market (Topical Hemostasis, Infusible Hemostasis, and Advanced Hemostasis) for Trauma, Surgery, Hemophilia, Myocardial Infarction, Stroke, and Thrombosis Applications: Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021" report at https://www.zionmarketresearch.com/report/hemostasis-products-market
Based on application, the market can be segmented into trauma, surgery, hemophilia, myocardial infarction, stroke, and thrombosis. Bleeding control is an important aim in surgery. Surgery and trauma are expected to be the fastest-growing segment. More than 80% of trauma deaths that occur in the operating room do so as a result of hemorrhage. Traumatic injury is a major global health problem, accounting for approximately 1 in 10 deaths worldwide.
North America region dominated the overall hemostasis products market and this region accounted for the largest share of the market in terms of revenue in 2015. This trend is expected to continue in the years to come. Increasing healthcare expenditure and technological advancement to provide innovative products are expected to drive the market growth in the near future. Thus, this region is expected to witness a significant growth in the hemostasis products market within the forecast period.
Inquire more about this report @ https://www.zionmarketresearch.com/inquiry/hemostasis-products-market
Asia Pacific is expected to be a lucrative market over the next few years on account of increased medical tourism and surgical procedures. Furthermore, hemostasis products market has the huge opportunity in the emerging markets of Asia Pacific due to the increasing aging population, rising health awareness and increasing investment in the healthcare sector especially in China and India.
Europe was another leading regional hemostasis products market in 2015. Europe hemostasis products market is expected to be driven due to the rise in geriatric population base, which is expected to ultimately lead to higher number of surgeries. Moreover, growth in this region is attributed to increasing concern regarding health among people.
Request a customized copy of report @ https://www.zionmarketresearch.com/custom/471
The Middle East & Africa is expected to witness the significant growth in coming years. The rapid growth of hemostasis products market will be driven by the increasing healthcare awareness coupled with advancement in technology. Latin America is another important regional market and is expected to experience significant growth over the forecast period. The growth is mainly due to the increasing demand for soft tissue repair treatment coupled with technological advancement. Thus, all aforementioned parameters are expected to propel the market growth in this region.
Some of the key players in the market such as Pfizer, Inc., Medtronic plc, Abbott Laboratories, Johnson & Johnson, Integra LifeSciences Corporation, HemCon Medical Technologies, Inc., Grifols, S.A., CSL Behring LLC, C. R. Bard, Inc. and Baxter International, Inc.
Purchase a direct copy of report with TOC @ https://www.zionmarketresearch.com/buynow/su/hemostasis-products-market
This report segments the global hemostasis products market as follows:
Global Hemostasis Products Market: Product Segment Analysis
- Topical Hemostasis
- Collagen
- Oxidized Regenerated Cellulose
- Gelatin
- Polysaccharide
- Infusible Hemostasis
- Platelet Concentrates from Donor Blood
- FVIII Derived from Blood
- Fresh Frozen Plasma
- Prothrombin Complex
- Advanced Hemostasis
- Flowable
- Thrombin
- Fibrin
- Synthetic Sealants
Global Hemostasis Products Market: Application Segment Analysis
- Trauma
- Surgery
- Hemophilia
- Myocardial Infarction
- Stroke
- Thrombosis
Global Hemostasis Products Market: Regional Segment Analysis
- North America
- U.S.
- Europe
- Germany
- France
- UK
- Asia Pacific
- China
- Japan
- India
- Latin America
- Brazil
- The Middle East & Africa
Related Reports:
- Respiratory Disease Testing Market: https://www.zionmarketresearch.com/report/respiratory-disease-testing-market
- Implantable Drug Delivery Devices Market: https://www.zionmarketresearch.com/report/implantable-drug-delivery-devices-market
- Pain Management Devices Market: https://www.zionmarketresearch.com/report/pain-management-devices-market
- Reprocessed Medical Devices Market: https://www.zionmarketresearch.com/report/reprocessed-medical-devices-market
- Injectable Drug Delivery Market: https://www.zionmarketresearch.com/report/injectable-drug-delivery-market
About Us:
Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research
Follow Us Twitter: https://twitter.com/zion_research
Contact Us: Joel John 4283, Express Lane, Suite 634-143, Sarasota, Florida 34249, United States Tel: +49-322 210 92714 USA/Canada Toll-Free No.1-855-465-4651 Email: [email protected] Website: https://www.zionmarketresearch.com/


OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Washington Post Publisher Will Lewis Steps Down After Layoffs
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances 



